☰

Brendan T. Harmon, Ph.D. - Publications

Affiliations: 
Pharmaceutical Science Northeastern University, Boston, MA, United States 
Area:
Parkinson\\\'s disease, gene therapy, intranasal delivery
Tree Info Grants Similar researchers PubMed Report error

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Aly AE, Harmon B, Padegimas L, Sesenoglu-Laird O, Cooper MJ, Yurek DM, Waszczak BL. Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brain. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30472323 DOI: 10.1016/J.Nano.2018.11.006  0.604
2018 Aly AE, Harmon BT, Padegimas L, Sesenoglu-Laird O, Cooper MJ, Waszczak BL. Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson's Disease. Molecular Neurobiology. PMID 29779176 DOI: 10.1007/S12035-018-1109-6  0.57
2014 Harmon BT, Aly AE, Padegimas L, Sesenoglu-Laird O, Cooper MJ, Waszczak BL. Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain. Gene Therapy. 21: 514-21. PMID 24670994 DOI: 10.1038/Gt.2014.28  0.597
Show low-probability matches.